Sectors
Gilead's hepatitis C drugs largely cost-effective in U.S.: study
New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses.
Bank of Japan to maintain aggressive stimulus, recovery view
The Bank of Japan is set to maintain its massive stimulus program on Tuesday and signal its conviction that a steady economic recovery will help achieve its ambitious price target without immediate, additional monetary easing.
Venezuela puts debt service before food imports as cash dries up: sources
Venezuela's government has told the country's food industry that it is limiting dollar disbursements for food imports so that it can pay down foreign debt amid low oil prices, according to two sources with direct knowledge of the situation.
Business leaders see peace boost if Netanyahu loses Israeli election
An upset victory by Israel's centre-left opposition in Tuesday's election could be a welcome change for a business and corporate sector eager for the "peace dividend" that might come with a government willing to talk with the Palestinians.